Cdk2 is dispensable for cell cycle inhibition and tumor suppression mediated by p27(Kip1) and p21(Cip1)
- PMID: 15950907
- DOI: 10.1016/j.ccr.2005.05.006
Cdk2 is dispensable for cell cycle inhibition and tumor suppression mediated by p27(Kip1) and p21(Cip1)
Abstract
p27(Kip1) and p21(Cip1) are thought to suppress tumor growth and prevent cell cycle progression by inhibiting Cdk2-cyclin E/A kinases. Since Cdk2 is dispensable for mitotic cell division, we analyzed the activity of these inhibitors in Cdk2-deficient cells. Ectopic expression of p27(Kip1) or p21(Cip1) efficiently inhibits cell cycle progression of Cdk2(-/-) fibroblasts. Loss of p27(Kip1) or p21(Cip1) confers similar proliferative advantages to Cdk2(+/+) and Cdk2(-/-) cells. Moreover, Cdk2 is dispensable for p21(Cip1)-induced cell cycle arrest after DNA damage. Finally, ablation of Cdk2 in p27(Kip1) null mice does not suppress their phenotypic defects, including development of pituitary tumors. These results indicate that Cdk2 is not an essential target for p27(Kip1) and p21(Cip1) in cell cycle inhibition and tumor suppression.
Similar articles
-
Loss of p27(Kip1) but not p21(Cip1) decreases survival and synergizes with MYC in murine lymphomagenesis.EMBO J. 2002 Jul 15;21(14):3739-48. doi: 10.1093/emboj/cdf364. EMBO J. 2002. PMID: 12110586 Free PMC article.
-
Cdc2-cyclin E complexes regulate the G1/S phase transition.Nat Cell Biol. 2005 Aug;7(8):831-6. doi: 10.1038/ncb1284. Epub 2005 Jul 10. Nat Cell Biol. 2005. PMID: 16007079
-
Adhesion-dependent control of cyclin E/cdk2 activity and cell cycle progression in normal cells but not in Ha-ras transformed NRK cells.Exp Cell Res. 1996 Nov 25;229(1):86-92. doi: 10.1006/excr.1996.0346. Exp Cell Res. 1996. PMID: 8940252
-
p27(kip1) functional regulation in human cancer: a potential target for therapeutic designs.Curr Med Chem. 2005;12(14):1589-605. doi: 10.2174/0929867054367149. Curr Med Chem. 2005. PMID: 16022660 Review.
-
Cdk2 as a master of S phase entry: fact or fake?Cell Cycle. 2004 Jan;3(1):35-7. Cell Cycle. 2004. PMID: 14657662 Review.
Cited by
-
Limited redundancy in phosphorylation of retinoblastoma tumor suppressor protein by cyclin-dependent kinases in acute lymphoblastic leukemia.Am J Pathol. 2006 Sep;169(3):1074-9. doi: 10.2353/ajpath.2006.051137. Am J Pathol. 2006. PMID: 16936279 Free PMC article.
-
Deregulation of the cyclin-dependent kinase inhibitor p27 as a putative candidate for transformation in Chlamydia trachomatis infected mesenchymal stem cells.AIMS Microbiol. 2023 Feb 28;9(1):131-150. doi: 10.3934/microbiol.2023009. eCollection 2023. AIMS Microbiol. 2023. PMID: 36891539 Free PMC article.
-
A requirement for cyclin-dependent kinase 6 in thymocyte development and tumorigenesis.Cancer Res. 2009 Feb 1;69(3):810-8. doi: 10.1158/0008-5472.CAN-08-2473. Epub 2009 Jan 20. Cancer Res. 2009. PMID: 19155308 Free PMC article.
-
Targeting CDKs in cancer therapy: advances in PROTACs and molecular glues.NPJ Precis Oncol. 2025 Jun 28;9(1):204. doi: 10.1038/s41698-025-00931-8. NPJ Precis Oncol. 2025. PMID: 40581698 Free PMC article. Review.
-
Cyclin-dependent kinase 2 (CDK2) is a key mediator for EGF-induced cell transformation mediated through the ELK4/c-Fos signaling pathway.Oncogene. 2016 Mar 3;35(9):1170-9. doi: 10.1038/onc.2015.175. Epub 2015 Jun 1. Oncogene. 2016. PMID: 26028036 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous